Merging multimodal digital biomarkers into “Digital Neuro Fingerprints” for precision neurology in dementias. the promise of the right treatment for the right patient at the right time in the age of AI
Loading...
Author (Corporation)
Publication date
2026
Type of student thesis
Course of study
Collections
Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Frontiers in Digital Health
Special issue
DOI of the original publication
Link
Series
Series number
Volume
7
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Frontiers Research Foundation
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
Digital biomarkers are revolutionizing medicine in ways that were unimaginable a few years ago. Consequently, precision medicine approaches now realistically can promise personalization, i.e., the right treatments for the right patients at the right time, including earlier, targeted interventions which lead to a major paradigm shift in how medicine is practiced from reactive to preventive action. Although the scientific evidence is clear on the power of digital biomarkers, there is an unmet need for translating these findings into actionable insights in clinical practice. In this paper, we focus on Alzheimer's disease and related dementias (ADRD), and how digital biomarkers could empower clinical decision making in its preclinical stages. We argue that a new all-encompassing score is needed, akin to a BrainHealth Index linked to the established and validated risk stratifications frameworks and is directed at the prevention of ADRD. Specifically, we propose the new concept “Digital Neuro Fingerprint (DNF)”, built with simultaneous collection of multimodal digital biomarkers (speech, gait, eye movements etc.) from smartphone based augmented reality or virtual reality while an individual is immersed in activities of daily living. Fusing the captured multimodal digital biomarkers, data is automatically analyzed with custom combinations of machine- and deep-learning approaches and enhanced with explainable artificial intelligence (XAI) and uncertainty quantifications. We argue that DNF is useful for capturing ADRD progression and should supersede the biomarkers that are invasive and expensive to obtain, offering a sensitive and highly specific score that measures meaningful aspects of health for the patients in high-frequency intervals.
Keywords
Subject (DDC)
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
2673-253X
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Gold
License
Citation
Tarnanas, I., Seixas, A., Wyss, M., Vlamos, P., & Cöltekin, A. (2026). Merging multimodal digital biomarkers into “Digital Neuro Fingerprints” for precision neurology in dementias. the promise of the right treatment for the right patient at the right time in the age of AI. Frontiers in Digital Health, 7. https://doi.org/10.3389/fdgth.2025.1727707